- Target
- EF-1 α1/2
- Reactivity
- Human,Mouse,Rat
- Application
- WB,ELISA
- MW(Calculated)
- --
- MW(Observed)
- 50kD
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-1:2000;ELISA 1:20000;Not yet tested in other applications.
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from the N-terminal region of human EF-1 α1/2.
- Sequence
- --
- Specificity
- EF-1 α1/2 Polyclonal Antibody detects endogenous levels of EF-1 α1/2 protein.
- Gene Name
- EEF1A1/EEF1A2/EEF1A1P5
- Protein Name
- Elongation factor 1-alpha 1/Elongation factor 1-alpha 2/Putative elongation factor 1-alpha-like 3
- Other Name
- EEF1A1;EEF1A;EF1A;LENG7;Elongation factor 1-alpha 1;EF-1-alpha-1;Elongation factor Tu;EF-Tu;Eukaryotic elongation factor 1 A-1;eEF1A-1;Leukocyte receptor cluster member 7;EEF1A2;EEF1AL;STN;Elongation factor 1-alpha 2;EF-1-alpha-2;Eukaryotic elongation factor 1 A-2;eEF1A-2;Statin-S1;EEF1A1P5;EEF1AL3;Putative elongation factor 1-alpha-like 3;EF-1-alpha-like 3;Eukaryotic elongation factor 1 A-like 3;eEF1A-like 3;Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5
- Organism-1
- Human
- Gene ID-1
- 1915;1917
- SwissProt-1
- P68104;Q05639;Q5VTE0
- Organism-2
- Mouse
- Gene ID-2
- 13627;13628
- SwissProt-2
- --
- Organism-3
- Rat
- Gene ID-3
- 171361;24799
- SwissProt-3
- P62630;P62632
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm . Nucleus . Nucleus, nucleolus . Cell membrane . Colocalizes with DLC1 at actin-rich regions in the cell periphery (PubMed:19158340). Translocates together with ZPR1 from the cytoplasm to the nucleus and nucleolus after treatment with mitogens (PubMed:8650580). Localization at the cell membrane depends on EEF1A1 phosphorylation status and the presence of PPP1R16B (PubMed:26497934). .